Tabula Rasa Ventures

2A Biosciences is a pharmaceutical company founded in 2022 and based in California, USA. It specializes in developing small molecule drugs aimed at treating inflammatory diseases by utilizing 2A agonists that target the serotonin system. Currently operating in stealth mode, the company is focused on advancing its innovative therapeutic solutions to address various inflammatory conditions.

Enthea is a company that focuses on enhancing mental health treatment options by providing access to safe and affordable psychedelic-assisted therapy as a workplace benefit. It partners with businesses to offer benefit plans that cover therapeutic services, facilitating coverage for employees seeking these critical mental health treatments. Enthea has developed a trusted network of certified practitioners specializing in Ketamine-Assisted Therapy and Psychedelic-Assisted Therapy. By building these networks and creating benefit plans for early adopter employers, Enthea aims to accelerate the acceptance and integration of psychedelic therapies into mainstream healthcare, ensuring consumers can access necessary treatments more easily and affordably.

Wavepaths, established in 2018 and based in London, specializes in developing accessible technology for psychedelic therapy. The company creates personalized soundtracks using intelligent technologies and immersive media, aiming to facilitate inner exploration and emotional reconnection during drug-free therapeutic sessions. Their offerings span the fields of information technology, healthcare, and personal health.

Natural MedTech is a biotechnology-based pharmaceutical manufacturer specializing in neurological medicines. The company focuses on developing psychedelic therapies to address significant and often overlooked neurological needs. Its research centers on psilocybin, MDMA, and tryptamines, which are recognized for their therapeutic potential. By conducting formal studies in Australia, Natural MedTech aims to provide innovative solutions for conditions such as depression and addiction, ultimately enabling healthcare professionals to offer more effective treatments to their patients.

Psynautics is a research platform focused on advancing the fields of neuroscience, pharmacology, and consciousness. The company addresses existing gaps in these disciplines by utilizing big data and mobile electroencephalography devices. This innovative approach allows for the real-time logging of mind-altering experiences through an ecological momentary assessment service. By facilitating the collection and analysis of neuroscientific data, Psynautics enables academic and clinical researchers to explore fundamental questions about the mind and brain, thus contributing to a deeper understanding of consciousness and its related phenomena.

Terran Biosciences Inc. is a biotechnology company focused on developing innovative solutions for neurological and mental health disorders. Established in 2017 and headquartered in New York, the company offers a diverse range of products, including a therapeutics pipeline, a medical device program, and a precision medicine platform. Terran Biosciences aims to create impactful therapies and technologies that can significantly improve the quality of life for patients suffering from neurological and psychiatric conditions.